TIL
Instil Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.79
−2.03%Next report
Analyst consensus
- Next report date
- Nov 16, 2026
- EPS estimate
- -$0.17
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.63
- EPS estimate
- -$0.35
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -8.2%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.35 | -$0.63 | Miss -80.00% | — |
| May 15, 2026 | -$0.62 | -$0.62 | In line | — |
| Mar 27, 2026 | -$2.31 | -$1.21 | Beat 47.62% | — |
| Nov 13, 2025 | -$2.00 | -$2.01 | Miss -0.50% | — |
| Aug 13, 2025 | -$1.72 | -$3.24 | Miss -88.37% | — |
| Mar 4, 2025 | -$3.75 | -$1.82 | Beat 51.47% | — |
| Nov 13, 2024 | -$2.08 | -$3.54 | Miss -70.19% | — |
| Aug 13, 2024 | -$3.04 | -$2.29 | Beat 24.67% | — |
| May 10, 2024 | -$2.16 | -$3.74 | Miss -73.15% | — |
| Mar 21, 2024 | -$2.84 | -$1.99 | Beat 29.93% | $7.7M |
| Nov 13, 2023 | -$2.80 | -$10 | Miss -271.43% | — |
| Aug 14, 2023 | -$4.00 | -$2.20 | Beat 45.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026